STOCK TITAN

Attovia Therapeutics: Alamar HoldCo reports 7.1% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Attovia Therapeutics, Inc. (ATTO) is the issuer whose common stock Alamar HoldCo, LLC reported beneficially owning in a statement tied to a September 30, 2026 event. Alamar HoldCo is the record owner of 3,229,278 shares and reported sole power to vote and dispose of those shares.

Alamar HoldCo may be deemed to own 7.1% of ATTO’s common stock, calculated using 45,651,262 shares outstanding as of August 31, 2026.

Shares beneficially owned 3,229,278 shares Alamar HoldCo, LLC is the record owner and reports sole voting and dispositive power.
Percentage of class 7.1% Alamar HoldCo may be deemed to beneficially own this percentage of ATTO common stock.
Shares outstanding 45,651,262 shares ATTO common stock outstanding as of August 31, 2026; used to calculate the reported percentage.
beneficially own regulatory
"may be deemed to beneficially own 7.1%"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole dispositive power regulatory
"has sole power to dispose of 3,229,278 shares"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ATTO shares does Alamar HoldCo own?

Alamar HoldCo, LLC is the record owner of 3,229,278 shares of Attovia Therapeutics common stock and may be deemed to beneficially own 7.1% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





04987L102

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Alamar HoldCo, LLC
Signature:/s/ Yuling Luo
Name/Title:Yuling Luo, President
Date:11/13/2026

Keep reading